These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 19925559

  • 1. Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis.
    Shibata N, Yamamoto T, Hiroi A, Omi Y, Kato Y, Kobayashi M.
    Neuropathology; 2010 Aug; 30(4):353-60. PubMed ID: 19925559
    [Abstract] [Full Text] [Related]

  • 2. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
    Shibata N, Kawaguchi-Niida M, Yamamoto T, Toi S, Hirano A, Kobayashi M.
    Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
    [Abstract] [Full Text] [Related]

  • 3. Protein-bound crotonaldehyde accumulates in the spinal cord of superoxide dismutase-1 mutation-associated familial amyotrophic lateral sclerosis and its transgenic mouse model.
    Shibata N, Kawaguchi M, Uchida K, Kakita A, Takahashi H, Nakano R, Fujimura H, Sakoda S, Ihara Y, Nobukuni K, Takehisa Y, Kuroda S, Kokubo Y, Kuzuhara S, Honma T, Mochizuki Y, Mizutani T, Yamada S, Toi S, Sasaki S, Iwata M, Hirano A, Yamamoto T, Kato Y, Sawada T, Kobayashi M.
    Neuropathology; 2007 Feb; 27(1):49-61. PubMed ID: 17319283
    [Abstract] [Full Text] [Related]

  • 4. Activation of signal transducer and activator of transcription-3 in the spinal cord of sporadic amyotrophic lateral sclerosis patients.
    Shibata N, Kakita A, Takahashi H, Ihara Y, Nobukuni K, Fujimura H, Sakoda S, Sasaki S, Iwata M, Morikawa S, Hirano A, Kobayashi M.
    Neurodegener Dis; 2009 Feb; 6(3):118-26. PubMed ID: 19372705
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M, Salvaneschi E, Bontempi L, Petese A, Manzo A, Rossi D, Salmona M, Collina S, Bigini P, Curti D.
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
    Tokuda E, Okawa E, Watanabe S, Ono S.
    Hum Mol Genet; 2014 Mar 01; 23(5):1271-85. PubMed ID: 24163136
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
    Chang-Hong R, Wada M, Koyama S, Kimura H, Arawaka S, Kawanami T, Kurita K, Kadoya T, Aoki M, Itoyama Y, Kato T.
    Exp Neurol; 2005 Jul 01; 194(1):203-11. PubMed ID: 15899257
    [Abstract] [Full Text] [Related]

  • 10. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis.
    Vercruysse P, Sinniger J, El Oussini H, Scekic-Zahirovic J, Dieterlé S, Dengler R, Meyer T, Zierz S, Kassubek J, Fischer W, Dreyhaupt J, Grehl T, Hermann A, Grosskreutz J, Witting A, Van Den Bosch L, Spreux-Varoquaux O, GERP ALS Study Group, Ludolph AC, Dupuis L.
    Brain; 2016 Apr 01; 139(Pt 4):1106-22. PubMed ID: 26984187
    [Abstract] [Full Text] [Related]

  • 11. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
    Wootz H, Weber E, Korhonen L, Lindholm D.
    Neuroscience; 2006 Dec 01; 143(2):419-30. PubMed ID: 16973300
    [Abstract] [Full Text] [Related]

  • 12. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
    Watanabe M, Dykes-Hoberg M, Culotta VC, Price DL, Wong PC, Rothstein JD.
    Neurobiol Dis; 2001 Dec 01; 8(6):933-41. PubMed ID: 11741389
    [Abstract] [Full Text] [Related]

  • 13. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
    Turner BJ, Bäumer D, Parkinson NJ, Scaber J, Ansorge O, Talbot K.
    BMC Neurosci; 2008 Oct 28; 9():104. PubMed ID: 18957104
    [Abstract] [Full Text] [Related]

  • 14. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.
    Yoshii Y, Otomo A, Pan L, Ohtsuka M, Hadano S.
    Neurosci Res; 2011 Jul 28; 70(3):321-9. PubMed ID: 21453731
    [Abstract] [Full Text] [Related]

  • 15. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
    Feng X, Peng Y, Liu M, Cui L.
    Neuropharmacology; 2012 Feb 28; 62(2):1004-10. PubMed ID: 22056419
    [Abstract] [Full Text] [Related]

  • 16. Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation.
    Shibata N, Hirano A, Hedley-Whyte ET, Dal Canto MC, Nagai R, Uchida K, Horiuchi S, Kawaguchi M, Yamamoto T, Kobayashi M.
    Acta Neuropathol; 2002 Aug 28; 104(2):171-8. PubMed ID: 12111360
    [Abstract] [Full Text] [Related]

  • 17. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients.
    Johann S, Heitzer M, Kanagaratnam M, Goswami A, Rizo T, Weis J, Troost D, Beyer C.
    Glia; 2015 Dec 28; 63(12):2260-73. PubMed ID: 26200799
    [Abstract] [Full Text] [Related]

  • 18. Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models.
    Kato S, Kato M, Abe Y, Matsumura T, Nishino T, Aoki M, Itoyama Y, Asayama K, Awaya A, Hirano A, Ohama E.
    Acta Neuropathol; 2005 Aug 28; 110(2):101-12. PubMed ID: 15983830
    [Abstract] [Full Text] [Related]

  • 19. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
    Tanaka K, Kanno T, Yanagisawa Y, Yasutake K, Hadano S, Yoshii F, Ikeda JE.
    Exp Neurol; 2011 Nov 28; 232(1):41-52. PubMed ID: 21867702
    [Abstract] [Full Text] [Related]

  • 20. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
    Lasiene J, Komine O, Fujimori-Tonou N, Powers B, Endo F, Watanabe S, Shijie J, Ravits J, Horner P, Misawa H, Yamanaka K.
    Acta Neuropathol Commun; 2016 Feb 18; 4():15. PubMed ID: 26891847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.